Meningeal carcinomatosis: A rare complication of bladder cancer;La meningite carcinomateuse: Une complication rare du cancer de la vessie

Revue de Medecine Interne

Volumn 18, Issue 5, 1997, Pages 402-406

  Hasbini, A ^a   Himberlin, C ^b   Beguinot, I ^b   Bonnet Gausserand, F ^b   Coninx, P ^a  

^a INSTITUT JEAN GODINOT   (France)

^b SERVICE DE DERMATOLOGIE   (France)

Author keywords

chemotherapy; meningeal carcinomatosis; side effect; transitional cell carcinoma

Indexed keywords

CISPLATIN; METHOTREXATE; METOCLOPRAMIDE; ONDANSETRON; PIRARUBICIN; PREDNISOLONE; VINBLASTINE;

ADULT; ARTICLE; BLADDER CANCER; BLOOD BRAIN BARRIER; CARCINOMATOUS MENINGITIS; CASE REPORT; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; CYSTECTOMY; HEADACHE; HUMAN; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; METASTASIS; TRANSITIONAL CELL CARCINOMA; BLADDER TUMOR; CANCER INVASION; MENINGIOMA; MIDDLE AGED; PATHOLOGY; REVIEW;

CARCINOMA, TRANSITIONAL CELL; HUMANS; MALE; MENINGEAL NEOPLASMS; MIDDLE AGED; NEOPLASM INVASIVENESS; URINARY BLADDER NEOPLASMS;

EID: 0031005509     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(97)82512-X     Document Type: Article

References (36)

1. Mandell S, Wernz J, Morales P et al. Carcinomatous meningitis from transitional cell carcinoma of bladder. Urology 1985;25:520-1
2. Hust MH, Pfitzer P. Cerebrospinal fluid and mestastasis of transitional cell carcinoma of the bladder. Acta Cytol 1982; 26:217-23
3. Raghavan D, Chye RWM, Treatment of carcinomatous meningitis from transitional cell carcinoma of the bladder Br J Urol 1991;67:438-40
4. Sternberg CN, Yagoda A, Scher HI et al. Methotrexate, vinblastin, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse. Cancer 1989;64:2448-58
5. Bishop JR, Jr., Moul JW, Maldonado L, McLeod DG. Transitional cell carcinomatous meningitis after M-VAC (methotrexate, vinblastin, doxorubicin and cisplatin). Urology 1990;36:373-7
6. Logothetis CJ, Dexeus FH, Finn L et al. A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with mestastatic urothelial tumors. J Clin Oncol 1990;8:1050-5
7. Logothetis CJ, Dexeus FH, Sella A et al. Escalated therapy for refractory urothelia tumors: methotrexate-vinblastin-doxorubicin-cisplatin plus unglycosylated recombinant human granulocyte-macrophage colony-stimulating factor. J Natl Cancer Inst 1990;82:667-72
8. Boutan-Laroze A, Mahjoubi M, Droz JP et al. M-VAC (methotrexate, vinblastin, doxorubicin and cisplatin) for advanced carcinoma of the bladder. Eur J Cancer 1991;27:1690-4
9. Culine S, Guastalla JP, Theodore C, Droz JP. Chimiothérapie des tumeurs urohéliales de la vessie. Bull Cancer 1994;81:300-11
10. Dirix LY, Van Oosterom AT. Neoadjuvant and adjuvant therapy for invasive bladder tumours. Eur J Cancer 1991;27:330-3
11. Studer UE, Bacchi M, Biedermann C et al. Adjuvant cisplatin chemotherapy following cystectomy for bladder cancer: results of a prospective randomized trial. J Urol 1994;152: 81-4
12. Smith MR, Kantoff PW. Neoadjuvant and adjuvant chemotherapy for invasive bladder cance. Semin Oncol 1995; 12:625-32
13. Eberth CJ. Zur Entwicklung des Epitheliomas der Pia und der Lunge. Virchows Arch Path Anat 1870;49:51-63
14. Gonzalez-Vitale JV, Garcia-Bunuel R. Meningeal carcinomatosis. Cancer 1976;37:2906-11
15. Coninx P. Méningites carcinomateuses. Concours Méd 1979;101:5715-24
16. Ushio Y, Posner JB, Shapiro WR. Chemotherapy of experimental meningeal carcinomatosis. Cancer Res 1977;37: 1232-6
17. Posner JB. Neurological complications of systemic cancer Med Clin North Am 1971;55:625-46
18. Posner JB, Chernik NL. Intracranial metastases from systemic cancer. Adv Neurol 1978;19:579
19. Eng C, Cunningham D, Quade BJ et al. Meningeal carcinomatosis from transitional cell carcinoma of the bladder. Cancer 1993;72:553-7
20. Bloch JL, Nieh PT, Walzak MP. Brain metastases from transitional cell carcinoma. J Urol 1987;137:97-9
21. Hussein AM, Savaraj N, Feun LG et al. Carcinomatous meningitis from transitional cell carcinoma of the bladder: Case report. J Neuro-Oncol 1989;7:255-60
22. Kabalin JN, Freiha FS, Torti FM. Brain metastases from transitional cell carcinoma of the bladder. J Urol 1988; 140:820-4
23. Abrams HL, Spiro R, Goldstein N. Metastases in carcinoma. Analysis of 1000 autopsied cases. Cancer 1950;25: 74-85
24. Olson ME, Chernik NL, Posner JB. Infitration of leptomeninges by systemic cancer. Arch Neurol 1974;30:122-37
25. Wasserstrom WR, Glass JP, Posner JB. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer 1982;49:759-72
26. Little JR, Dale AJ, Okazaki H. Meningeal carcinomatosis clinical manifestations. Arch Neurol 1974;30:138-43
27. Jayson GC, Howell A. Carcinomatous meningitis in solid tumours. Ann Oncol 1996;7:773-86
28. Sze G, Soletsky S, Bronen R, Krol G. MR imaging of the cranial meninges with emphasis on contrast enhancement and meningeal carcinomatosis. Am J Neuro Radial 1989;10: 965-75
29. M, Tanaka R, Tanaka N. Correlation of MRI and clinique features in meningeal carcinomatosis. Neuroradiology 1993;35:512-5
30. Sadrin R, Coninx P, Evrard G, Simatos A. L'envahissement leptoméningé au cours de l'évolution des tumeurs solides. Apport de la cytologie. Arch Anat Cytol Pathol 1979;27: 325-7
31. Yagoda A. Chemotherapy of urothelial tract tumors. Cancer 1987;60:575-85
32. MacDonell LA, Potter PE, Leslie RA. Localized changes in blood-brain barrier permeability following the administration of antineoplastic drugs. Cancer Res 1978;38:2930-4
33. Honn KV, Tang DG, Grossi IM et al. Enhanced endothelial cell retraction mediated by 12(S)-HETE: a proposed mechanism for the role of platelets in tumor cell metastasis. Exp Cell Res 1994;210:1-9
34. Missirlis E, Whaley M, Lhotak S, Orr FW. Endothelial injury causes degradation of adjacent basement membranes and promotes their invasion by A549 carcinoma cells. Invasion Metastasis 1992;12:35-46
35. Kantak SS, Diglio CA, Onoda JM. Low dose radiation-induced endothelial cell retraction. Int J Radiat Biol 1993;64:319-28
36. Camussi G, Turello E, Baglioni C. Tumor necrosis factor alters cytoskeletal organization and barrier function of endothelial cells. Int Arch Allergy Appl Immunol 1991; 96:84-91